• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在慢性粒细胞白血病中,一种细胞癌基因易位至费城染色体。

A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia.

作者信息

de Klein A, van Kessel A G, Grosveld G, Bartram C R, Hagemeijer A, Bootsma D, Spurr N K, Heisterkamp N, Groffen J, Stephenson J R

出版信息

Nature. 1982 Dec 23;300(5894):765-7. doi: 10.1038/300765a0.

DOI:10.1038/300765a0
PMID:6960256
Abstract

The transforming genes of oncogenic retroviruses are homologous to a group of evolutionary conserved cellular onc genes. The human cellular homologue (c-abl) of the transforming sequence of Abelson murine leukaemia virus (A-MuL V) was recently shown to be located on chromosome 9. The long arm of this chromosome is involved in a specific translocation with chromosome 22, the Philadelphia translocation (Ph1), t(9; 22) (q34, q11), which occurs in patients with chronic myelocytic leukaemia (CML)3-5. Here we investigate whether the c-abl gene is included in this translocation. Using c-abl and v-abl hybridization probes on blots of somatic cell hybrids, positive hybridization is found when the 22q- (the Philadelphia chromosome), and not the 9q+ derivative of the translocation, is present in the cell hybrids. From this we conclude that in CML, c-abl sequences are translocated from chromosome 9 to chromosome 22q-. This finding is a direct demonstration of a reciprocal exchange between the two chromosomes and suggests a role for the c-abl gene in the generation of CML.

摘要

致癌逆转录病毒的转化基因与一组进化上保守的细胞癌基因同源。最近发现,阿贝尔森鼠白血病病毒(A-MuLV)转化序列的人类细胞同源物(c-abl)位于9号染色体上。该染色体的长臂与22号染色体发生特异性易位,即费城易位(Ph1),t(9; 22) (q34, q11),这种易位发生在慢性粒细胞白血病(CML)患者中3-5。在此,我们研究c-abl基因是否包含在这种易位中。在体细胞杂种印迹上使用c-abl和v-abl杂交探针,当细胞杂种中存在22q-(费城染色体)而不是易位的9q+衍生物时,发现阳性杂交。由此我们得出结论,在CML中,c-abl序列从9号染色体易位到22号染色体q-。这一发现直接证明了两条染色体之间的相互交换,并提示c-abl基因在CML的发生中起作用。

相似文献

1
A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia.在慢性粒细胞白血病中,一种细胞癌基因易位至费城染色体。
Nature. 1982 Dec 23;300(5894):765-7. doi: 10.1038/300765a0.
2
Localization of the human c-sis oncogene in Ph1-positive and Ph1-negative chronic myelocytic leukemia by in situ hybridization.通过原位杂交对人c-sis癌基因在Ph1阳性和Ph1阴性慢性粒细胞白血病中的定位。
Blood. 1984 Jan;63(1):223-5.
3
Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia.c - ab1癌基因的易位与慢性粒细胞白血病中费城染色体的存在相关。
Nature. 1983;306(5940):277-80. doi: 10.1038/306277a0.
4
Expression of a translocated c-abl gene in hybrids of mouse fibroblasts and chronic myelogenous leukaemia cells.易位型c-abl基因在小鼠成纤维细胞与慢性粒细胞白血病细胞杂交体中的表达。
Nature. 1986;319(6051):331-3. doi: 10.1038/319331a0.
5
Structural organization of the bcr gene and its role in the Ph' translocation.bcr基因的结构组织及其在费城染色体易位中的作用。
Nature. 1985;315(6022):758-61. doi: 10.1038/315758a0.
6
C-abl and bcr are rearranged in a Ph1-negative CML patient.在一名Ph1阴性慢性粒细胞白血病患者中,C-abl和bcr发生了重排。
EMBO J. 1985 Mar;4(3):683-6. doi: 10.1002/j.1460-2075.1985.tb03683.x.
7
An 8-kilobase abl RNA transcript in chronic myelogenous leukemia.慢性粒细胞白血病中的一种8千碱基abl RNA转录本。
Proc Natl Acad Sci U S A. 1984 Sep;81(18):5648-52. doi: 10.1073/pnas.81.18.5648.
8
Altered transcription of an oncogene in chronic myeloid leukaemia.慢性髓细胞白血病中癌基因转录的改变。
Lancet. 1984 Mar 17;1(8377):593-5. doi: 10.1016/s0140-6736(84)90997-8.
9
Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia.慢性粒细胞白血病中与易位断点相邻的c-ab1癌基因的定位。
Nature. 1983;306(5940):239-42. doi: 10.1038/306239a0.
10
Chronic myeloid leukaemia and the Philadelphia translocation: do the c-sis oncogene and platelet-derived growth factor provide the link?
Leuk Res. 1983;7(6):817-20. doi: 10.1016/0145-2126(83)90076-0.

引用本文的文献

1
The BCL-2 protein family: from discovery to drug development.BCL-2蛋白家族:从发现到药物研发
Cell Death Differ. 2025 Apr 9. doi: 10.1038/s41418-025-01481-z.
2
A methyltransferase-independent role for METTL1 in tRNA aminoacylation and oncogenic transformation.METTL1在tRNA氨基酰化和致癌转化中不依赖甲基转移酶的作用。
Mol Cell. 2025 Mar 6;85(5):948-961.e11. doi: 10.1016/j.molcel.2025.01.003. Epub 2025 Jan 31.
3
Hematological and Biochemical Characteristics Associated with Cytogenetic Findern Alterations in Adult Patients with Acute Lymphoblastic Leukemia (ALL) from the Northern Region of Brazil.
巴西北部地区成年急性淋巴细胞白血病(ALL)患者细胞遗传学发现改变相关的血液学和生化特征
Biomedicines. 2024 Nov 29;12(12):2739. doi: 10.3390/biomedicines12122739.
4
Traffic light at DSB-transit regulation between gene transcription and DNA repair.基因转录与DNA修复之间DSB转运调控的信号灯。
FEBS Lett. 2025 Jan;599(2):177-189. doi: 10.1002/1873-3468.15024. Epub 2024 Sep 27.
5
Lysosomal acid lipase A modulates leukemia stem cell response to venetoclax/tyrosine kinase inhibitor combination therapy in blast phase chronic myeloid leukemia.溶酶体酸性脂肪酶A调节慢性髓性白血病急变期白血病干细胞对维奈托克/酪氨酸激酶抑制剂联合治疗的反应。
Haematologica. 2025 Jan 1;110(1):103-116. doi: 10.3324/haematol.2023.284716.
6
Advancements and Future Prospects in Molecular Targeted and siRNA Therapies for Chronic Myeloid Leukemia.分子靶向和 siRNA 疗法治疗慢性髓性白血病的进展和未来前景。
Biomolecules. 2024 May 30;14(6):644. doi: 10.3390/biom14060644.
7
RAPSYN-mediated neddylation of BCR-ABL alternatively determines the fate of Philadelphia chromosome-positive leukemia.RAPSYN 介导的 BCR-ABL 类泛素化决定费城染色体阳性白血病的命运。
Elife. 2024 Jun 12;12:RP88375. doi: 10.7554/eLife.88375.
8
Human ABL1 deficiency syndrome (HADS) is a recognizable syndrome distinct from ABL1-related congenital heart defects and skeletal malformations syndrome.人类 ABL1 缺陷综合征(HADS)是一种可识别的综合征,与 ABL1 相关的先天性心脏缺陷和骨骼畸形综合征不同。
Hum Genet. 2024 Jun;143(6):739-745. doi: 10.1007/s00439-024-02677-y. Epub 2024 May 14.
9
Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgrounds.力求让来自不同祖先背景的个人从基因组学进展中获得公平的益处。
Am J Hum Genet. 2024 May 2;111(5):809-824. doi: 10.1016/j.ajhg.2024.04.002. Epub 2024 Apr 19.
10
FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5.FL118 通过靶向 RNA 解旋酶 DDX5 成为对抗 BCR-ABL 抑制剂耐药的慢性髓性白血病的有效治疗药物。
Int J Mol Sci. 2024 Mar 26;25(7):3693. doi: 10.3390/ijms25073693.